Ikena Oncology, Inc. (NASDAQ:IKNA – Free Report) was the recipient of a significant decrease in short interest during the month of June. As of June 15th, there was short interest totalling 215,300 shares, a decrease of 22.9% from the May 31st total of 279,400 shares. Currently, 1.0% of the company’s stock are sold short. Based […]
Ikena Oncology, Inc. (NASDAQ:IKNA – Get Rating) – Equities research analysts at HC Wainwright issued their Q1 2023 earnings per share estimates for Ikena Oncology in a report released on Thursday, May 4th. HC Wainwright analyst A. Maldonado anticipates that the company will earn ($0.41) per share for the quarter. HC Wainwright has a “Buy” […]
HC Wainwright reiterated their buy rating on shares of Ikena Oncology (NASDAQ:IKNA – Get Rating) in a research report sent to investors on Thursday, MarketBeat reports. HC Wainwright currently has a $18.00 price objective on the stock. Separately, Credit Suisse Group cut their price objective on shares of Ikena Oncology from $16.00 to $13.00 and […]